These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29680411)

  • 1. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
    Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
    Xu LH; Wang Y; Chen ZY; Fang JP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological characteristics, cytogenetic profile, and outcome of RUNX1-RUNX1T1-positive acute myeloid leukemia: Experience of an Indian tertiary care center.
    Gupta R; Yadav S; Parashar Y; Rahman K; Singh MK; Chandra D; Gupta A; Nityanand S
    Int J Lab Hematol; 2020 Feb; 42(1):37-45. PubMed ID: 31725954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.
    Tsimberidou AM; Kantarjian HM; Wen S; Keating MJ; O'Brien S; Brandt M; Pierce S; Freireich EJ; Medeiros LJ; Estey E
    Cancer; 2008 Sep; 113(6):1370-8. PubMed ID: 18623376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
    Zhou T; Bloomquist MS; Ferguson LS; Reuther J; Marcogliese AN; Elghetany MT; Roy A; Rao PH; Lopez-Terrada DH; Redell MS; Punia JN; Curry CV; Fisher KE
    Pediatr Hematol Oncol; 2020 Feb; 37(1):76-89. PubMed ID: 31682773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
    Rogers HJ; Wang X; Xie Y; Davis AR; Thakral B; Wang SA; Borthakur G; Cantu MD; Margolskee EM; Philip JKS; Sukhanova M; Bagg A; Bueso-Ramos CE; Orazi A; Arber DA; Hsi ED; Hasserjian RP
    Am J Hematol; 2020 Jul; 95(7):799-808. PubMed ID: 32249963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
    Hu G; Lu A; Wu J; Jia Y; Zuo Y; Ding M; Zhang L
    Pediatr Hematol Oncol; 2021 Feb; 38(1):14-24. PubMed ID: 32803999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
    Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
    J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
    Lazzarotto D; Candoni A; Filì C; Forghieri F; Pagano L; Busca A; Spinosa G; Zannier ME; Simeone E; Isola M; Borlenghi E; Melillo L; Mosna F; Lessi F; Fanin R
    Leuk Res; 2017 Feb; 53():74-81. PubMed ID: 28056398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
    Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
    Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
    J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience].
    Piatkowska-Jakubas B; Mensah-Glanowska P; Salamańczuk Z; Skotnicki AB
    Przegl Lek; 2011; 68(6):291-5. PubMed ID: 22039664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
    Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H
    Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia.
    Abbas HA; Reville PK; Geppner A; Rausch CR; Pemmaraju N; Ohanian M; Sasaki K; Borthakur G; Daver N; DiNardo C; Bueso-Ramos C; Pierce S; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F; Kantarjian H; Kadia TM
    Leuk Lymphoma; 2021 Dec; 62(14):3402-3410. PubMed ID: 34380367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
    Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
    Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ
    Korean J Lab Med; 2010 Jun; 30(3):231-8. PubMed ID: 20603581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
    Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analyses of karyotypic characteristics and prognosis in pediatric acute myeloblastic leukemia].
    Ruan M; Wang YQ; Zhang L; Zou Y; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):725-8. PubMed ID: 23336225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.